We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
ACCEPT Reject
Already have an account? Sign in.

 Remember Me | Forgot Your Password?
Home Manage Alerts Archive Archive About Us Register Now   Not a User? Join now

GlaxoSmithKline Announces Changes At Company's Board Of Directors

March 17, 2016: 12:00 AM EST
GlaxoSmithKline PLC announced that Deryck Maughan, Stephanie Burns, Daniel Podolsky, and Hans Wijers will not seek reelection as members of the company’s board of directors during the annual general meeting on May 5, 2016. Maughan has served as an independent non-executive director for the company’s board of directors since 2004, and as the senior independent director since 2013. Burns, Podolsky, and Wijers have also served as independent directors for varying numbers of years.
"GlaxoSmithKline plc (the “Company”) Directorate changes", GlaxoSmithKline , March 17, 2016, © GlaxoSmithKline plc
Domains
PERSONAL CARE BUSINESS
Operations
Strategy
Geographies
Worldwide
EMEA
Europe
United Kingdom
Categories
Companies, Organizations
Press Release
Home | Privacy Policy | Terms and Conditions | Contact Us Copyright © 2000-2023 Business360 Inc. All Rights Reserved
Developed by Yuri Ingultsov Software Lab.